The vaccines available at vaccination centers today 15 October 2021 are Johnson & Johnson and Our Moderna, contrary to what was introduced on the first day of intensive vaccinations, the last Sunday, the AstraZeneca vaccine.
Social media is experiencing widespread debate about the types of confluence, among those who are reluctant to get the CORONAvirus vaccine because of its type or lack of efficacy.
What are these three vaccines? What are the criteria for choosing the type of vaccine in each campaign?
A member of the Scientific Committee against the Coronavirus Amanullah Al-Masadi said in a statement to jdd-tunisie on Sunday, 15 Utd 2021, that these fears and arguments are amateur, and the reason is the misleading news on social media platforms, especially Facebook, and the adoption of false and unclear information from sources that are not serious.
He continued that the Ministry of Health, the official body for taking information, explained its choice of types of vaccine for each age group, and stressed the effectiveness of the vaccine and its importance.
How to differ
Moderna vaccine is a new type called the RNA vaccine (ribose DNA), adopting the same approach as pfizer vaccine, the company says protects 94.5 percent, and the vaccine is given on two doses with a four-week interval.
The Johnson & Johnson vaccine is given as a single dose, which means no follow-up visits, and the vaccine is up to 85 percent effective against severe diseases.
AstraZeneca’s vaccine uses a harmless virus (the virus that causes the colds that infect chimpanzees) and is modified so that it cannot cause infection.
Regarding the reasons for the selection of the Moderna, Johnson & Johnson vaccines for the second day of intensive convergence, Al-Masadi explained to JDD-tunisie, that the allocation of the Johnson & Johnson vaccine to students and pupils enrolled on the Ministry of Higher Education database and pupils registered on the Ministry of Education database aged 18, because it is a one-dose vaccine which The second vaccine, Moderna, has the same characteristics as pfizer and is available in quantities that meet the required need.
AstraZeneca vaccine, which has proven effective with the over-40 age groups and has proved effective against the new Delta mutator, according to the Ministry of Health, was used with the over-40 age group, although the scientific committee confirmed the safety and efficacy of vaccination and approved it, noting that each vaccination arrives in Tunisia even if it is a donation passed on the laboratory to verify its safety first.
Criteria for choosing the type of vaccine
A member of the Scientific Committee against the Coronavirus Amanullah Al-Masadi, explained that the criteria for selecting converging are based on a complete strategy, first it must be in line with the target age group, and then the vaccine must be available in the necessary quantities in line with the number of registered, as well as provide conditions for maintaining vaccination, stressing that most of the vaccines used are close in efficacy and effectiveness against CORONAVIRUS.
One million and two hundred thousand vaccination doses are available for the second national day of intensive vaccinations for the 39-18 age group, according to The Ministry of Health’s affairs officer Ali Merabet.
Walid al-Hajjam, an adviser to the President of the Republic, said in a statement to National Channel 1 that 223,000 people received the vaccine against CORONAvirus today in the entire vaccination centers in the Republic, and until 11:30 a.m. on 15 Ut 2021.
More than half a million people received coronavirus, during the first day of intensive vaccinations, on 8 October 2021.
Translated by Rifi-JDD
